Filing Details
- Accession Number:
- 0001477932-15-006851
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-10 19:21:05
- Reporting Period:
- 2015-09-08
- Filing Date:
- 2015-11-10
- Accepted Time:
- 2015-11-10 19:21:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029125 | Sun Biopharma Inc. | SNBP | Pharmaceutical Preparations (2834) | 870543922 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1642684 | John Robert Sargent | 1951 Logan Ave Salt Lake City UT 84108 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-08 | 216,705 | $0.00 | 74,825 | No | 4 | S | Indirect | By Rare Principle, L.C. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Rare Principle, L.C. |
Footnotes
- Mr. Sargent (through his entity) sold $125,000 of the issuer's debt and 216,705 shares of the issuer's common stock for $125,000 pursuant to transactions reported in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission ("SEC") on August 13, 2015, Current Report on Form 8-K filed with the SEC on September 11, 2015, and Schedule 14C filed with the SEC on August 7, 2015, among others.